Skip to main content
. Author manuscript; available in PMC: 2016 Sep 15.
Published in final edited form as: Am J Cardiol. 2015 Jun 24;116(6):904–912. doi: 10.1016/j.amjcard.2015.06.016

Table 4.

Comparison of the HAS-BLED and OBRI risk scores for predicting major bleeding in WARCEF participants receiving warfarin or aspirin.

c-statistic
for HAS-BLED
c-statistic
for OBRI
p-value for
difference in c-statistics
NRI
Warfarin 0.61 (0.51-0.70) 0.72 (0.62-0.81) 0.03 0.32 (−0.18-0.37)
Aspirin 0.63 (0.50-0.77) 0.58 (0.43-0.71) 0.50 0.13 (−0.19-0.15)

Abbreviations: NRI, net reclassification index. For NRI, the directions of comparisons are for OBRI versus HAS-BLED.